SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹202 Cr | ₹175 Cr | ₹137 Cr | ₹171 Cr | ₹147 Cr |
What is the latest Total Current Liabilities ratio of SUDEEP PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹202 Cr |
| Mar2025 | ₹175 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | ₹171 Cr |
| Mar2022 | ₹147 Cr |
How is Total Current Liabilities of SUDEEP PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹202 Cr | 15.57 | |
| Mar2025 | ₹175 Cr | 27.35 | |
| Mar2024 | ₹137 Cr | -19.67 | |
| Mar2023 | ₹171 Cr | 16.23 | |
| Mar2022 | ₹147 Cr | - | |
Compare Total Current Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹15,002.7 Cr | 9.8% | 36.5% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 9.8% |
36.5% |
|
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses